The dipeptidyl peptidase-IV inhibitor gemigliptin alone or in combination with NVP-AUY922 has a cytotoxic activity in thyroid carcinoma cells. [electronic resource]
Producer: 20171017Description: 1010428317722068 p. digitalISSN:- 1423-0380
- Antineoplastic Agents -- pharmacology
- Apoptosis -- drug effects
- Blotting, Western
- Carcinoma -- pathology
- Cell Line, Tumor
- Cell Survival -- drug effects
- Dipeptidyl-Peptidase IV Inhibitors -- pharmacology
- Drug Synergism
- Flow Cytometry
- Humans
- Isoxazoles -- pharmacology
- Piperidones -- pharmacology
- Pyrimidines -- pharmacology
- Resorcinols -- pharmacology
- Signal Transduction -- drug effects
- Thyroid Neoplasms -- pathology
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.